Eli Lilly's Bold Move: Revolutionizing Mental Health with $3.8 Billion Psychedelic Investment
Eli Lilly's $3.8 billion investment in a psychedelic drug company marks a bold shift in mental health treatment, focusing on brain reset in a single session. L…